ConductScience.org, home

Paper11479219

Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells.

Kavallaris M and 6 others. Cancer Res, 2001. Cited by 185 papers, by iCite.

Cite this record

ConductScience Library. Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells. Papers, record 11479219. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11479219

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells.
PubMed
Journal
Cancer Res
PubMed
Year
2001
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
185
iCite
Relative citation ratio, by iCite
3.84
iCite
Revised in PubMed
2022-12-07
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kavallaris MM
2Tait ASA S
3Walsh BJB J
4He LL
5Horwitz SBS B
6Norris MDM D
7Haber MM

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Agents, PhytogenicMajor topic
Leukemia-Lymphoma, Adult T-CellMajor topic
MicrotubulesMajor topic
TubulinMajor topic
VinblastineMajor topic
VincristineMajor topic
Drug Resistance, Neoplasm
Electrophoresis, Gel, Two-Dimensional
Humans
Immunoblotting
Microtubule-Associated Proteins
Models, Molecular
Mutation
Protein Conformation
Protein Processing, Post-Translational
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Cited by67

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 185 citations.

PMIDTitleJournalYearIn PapersSource
42085471Synthetic data enables human-grade microtubule analysis with foundation models for segmentation.PLoS Comput Biol2026https://conductscience.org/library/papers/42085471PubMed
41924101Sulfonamide derivatives as tubulin polymerization inhibitors: advances in structural mechanisms, structure-activity relationships, and therapeutic potential in cancer treatment.RSC Adv2026https://conductscience.org/library/papers/41924101PubMed
41019978Distinct adaptive strategies to cisplatin, vinblastine and gemcitabine in a panel of chemoresistant bladder cancer cell lines.Cancer Drug Resist2025https://conductscience.org/library/papers/41019978PubMed
40982350New molecular targets in acute leukemias: cytoskeletal regulatory proteins.Biochem Soc Trans2025https://conductscience.org/library/papers/40982350PubMed
40872698Comparative Analysis of Chemotherapy Resistance Mechanisms in Humans and Companion Animals.Vet Sci2025https://conductscience.org/library/papers/40872698PubMed
40827484Tubulin inhibitors: an insight into new strategies to combat leukemia.Future Med Chem2025https://conductscience.org/library/papers/40827484PubMed
39281032Herbal Therapies for Cancer Treatment: A Review of Phytotherapeutic Efficacy.Biologics2024https://conductscience.org/library/papers/39281032PubMed
38805123Tubulin Complexity in Cancer and Metastasis.Adv Exp Med Biol2024https://conductscience.org/library/papers/38805123PubMed
37920438Exploring the mechanism of resistance to vincristine in breast cancer cells using transcriptome sequencing technology.Oncol Lett2023https://conductscience.org/library/papers/37920438PubMed
36629423Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation.J Enzyme Inhib Med Chem2023https://conductscience.org/library/papers/36629423PubMed
36551566Cellular and Molecular Effects of Eribulin in Preclinical Models of Hematologic Neoplasms.Cancers (Basel)2022https://conductscience.org/library/papers/36551566PubMed
36015179Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/36015179PubMed
35406424PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression.Cancers (Basel)2022https://conductscience.org/library/papers/35406424PubMed
34995063Inhibition of Microtubule Dynamics in Cancer Cells by Indole-Modified Latonduine Derivatives and Their Metal Complexes.Inorg Chem2022https://conductscience.org/library/papers/34995063PubMed
34771642Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers.Cancers (Basel)2021https://conductscience.org/library/papers/34771642PubMed
32823874Intrinsic and Extrinsic Factors Affecting Microtubule Dynamics in Normal and Cancer Cells.Molecules2020https://conductscience.org/library/papers/32823874PubMed
32636741Phytochemicals: Potential Lead Molecules for MDR Reversal.Front Pharmacol2020https://conductscience.org/library/papers/32636741PubMed
32467666N-alkylisatin-based microtubule destabilizers bind to the colchicine site on tubulin and retain efficacy in drug resistant acute lymphoblastic leukemia cell lines with less in vitro neurotoxicity.Cancer Cell Int2020https://conductscience.org/library/papers/32467666PubMed
32252403Utilizing Genome-Wide mRNA Profiling to Identify the Cytotoxic Chemotherapeutic Mechanism of Triazoloacridone C-1305 as Direct Microtubule Stabilization.Cancers (Basel)2020https://conductscience.org/library/papers/32252403PubMed
32108588Identification of a lathyrane-type diterpenoid EM-E-11-4 as a novel paclitaxel resistance reversing agent with multiple mechanisms of action.Aging (Albany NY)2020https://conductscience.org/library/papers/32108588PubMed

See all 67 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MAP44134PubTator's text mininghttps://conductscience.org/library/genes/4134NCBI Gene
RMDN2151393PubTator's text mininghttps://conductscience.org/library/genes/151393NCBI Gene
TUBA1B10376PubTator's text mininghttps://conductscience.org/library/genes/10376NCBI Gene
TUBB310381PubTator's text mininghttps://conductscience.org/library/genes/10381NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11479219

GET https://conductscience.org/api/papers/v1/11479219/cited_by?page=2